Ozempic

Product

Novo Nordisk's injectable semaglutide brand for type 2 diabetes

6 stories

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

FDA Approves Higher-Dose Wegovy for Weight Loss Treatment

Wegovy Users Face Five Times Greater Risk of Sudden Sight Loss Than Ozempic Users

Two Deaths Reported to Regulators Potentially Linked to Weight-Loss Injections

business24d ago

Hims & Hers Stock Surges Amid Weight-Loss Drug Battle with Novo Nordisk

GLP-1 Weight-Loss Drugs Linked to Bone and Tendon Injuries